Shumpei Ishikawa Selected Research

iminobiotin

1/2022

Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shumpei Ishikawa Research Topics

Disease

46	Neoplasms (Cancer) 10/2022 - 02/2003
10	Stomach Neoplasms (Stomach Cancer) 10/2022 - 10/2011
8	Adenocarcinoma 06/2020 - 10/2005
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2011
6	Neoplasm Metastasis (Metastasis) 10/2022 - 02/2006
6	Adenocarcinoma of Lung 06/2020 - 12/2005
6	Carcinoma (Carcinomatosis) 10/2016 - 04/2009
5	Carcinogenesis 01/2022 - 02/2003
5	Lung Neoplasms (Lung Cancer) 02/2013 - 03/2003
3	Inflammation (Inflammations) 01/2019 - 06/2004
3	Glioma (Gliomas) 01/2019 - 01/2004
2	Hypoxia (Hypoxemia) 11/2021 - 04/2007
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 12/2018
2	Adenocarcinoma in Situ 06/2020 - 07/2014
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 02/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 01/2012
2	Esophageal Squamous Cell Carcinoma 02/2015 - 02/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014 - 03/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 02/2003
2	Infections 01/2012 - 11/2011
2	Malaria 11/2011 - 06/2004
2	Glioblastoma (Glioblastoma Multiforme) 07/2011 - 01/2004
1	Cholangiocarcinoma 10/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Meningioma (Meningiomas) 01/2022
1	Dermatitis 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2019
1	Blister (Bulla) 12/2018
1	Pemphigus (Pemphigus Vulgaris) 12/2018

Drug/Important Bio-Agent (IBA)

11	Biological ProductsIBA 01/2022 - 01/2004
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2003
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2004
5	Messenger RNA (mRNA)IBA 01/2021 - 10/2003
5	Biomarkers (Surrogate Marker)IBA 06/2020 - 04/2014
5	OligonucleotidesIBA 12/2007 - 02/2003
4	Cadherins (E-Cadherin)IBA 10/2022 - 02/2013
4	AntigensIBA 10/2020 - 01/2017
4	RNA (Ribonucleic Acid)IBA 11/2019 - 11/2016
3	human ERBB2 proteinIBA 01/2022 - 09/2010
3	AntibodiesIBA 10/2020 - 01/2017
3	LigandsIBA 01/2020 - 01/2008
3	VimentinIBA 02/2013 - 11/2010
3	ErbB Receptors (EGF Receptor)IBA 11/2010 - 04/2007
3	Indicators and Reagents (Reagents)IBA 11/2010 - 12/2005
2	Immune Checkpoint InhibitorsIBA 01/2022 - 02/2017
2	CateninsIBA 01/2020 - 10/2011
2	Formaldehyde (Formol)FDA Link 01/2020 - 02/2017
2	GlypicansIBA 11/2017 - 02/2003
2	Pharmaceutical PreparationsIBA 11/2016 - 02/2014
2	ClaudinsIBA 09/2016 - 10/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015 - 02/2003
2	Cisplatin (Platino)FDA LinkGeneric 02/2014 - 11/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 06/2013 - 04/2009
2	Complementary DNA (cDNA)IBA 01/2012 - 10/2005
2	EnzymesIBA 11/2011 - 06/2004
1	Nucleic AcidsIBA 10/2022
1	Aspartate-tRNA LigaseIBA 10/2022
1	Interferon-gamma (Interferon, gamma)IBA 10/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	AcidsIBA 01/2022
1	Forkhead Box Protein M1IBA 01/2022
1	iminobiotinIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	silicon phthalocyanineIBA 01/2022
1	NucleotidesIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	ApelinIBA 11/2021
1	AutoantigensIBA 10/2020
1	RibonucleoproteinsIBA 10/2020
1	AgarIBA 06/2020
1	Colloids (Colloid)IBA 06/2020
1	Trefoil Factor-1IBA 06/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 11/2019
1	rhoA GTP-Binding ProteinIBA 11/2019
1	AmphiregulinIBA 01/2019
1	MDS1 and EVI1 Complex Locus ProteinIBA 01/2019
1	Immune Checkpoint ProteinsIBA 01/2019
1	Croton OilIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	OvalbuminIBA 01/2019
1	OxazoloneIBA 01/2019
1	Proline (L-Proline)FDA Link 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2019
1	EpitopesIBA 12/2018
1	Desmoglein 3IBA 12/2018

Therapy/Procedure

7	Therapeutics 10/2022 - 11/2016
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
3	Immunotherapy 10/2020 - 01/2017
2	Precision Medicine 01/2022 - 01/2018
2	Nephroureterectomy 06/2014 - 04/2014
1	Molecular Targeted Therapy 06/2020
1	Aftercare (After-Treatment) 01/2020
1	Lasers (Laser) 01/2020